Cerebral blood flow frequently decreases following the intravenous administration of chlorpromazine, apparently a result of the reduction in arterial blood pressure. If arterial blood pressure does not decrease, cerebral blood flow is not altered. Chlorpromazine does not exert a depressant effect on cerebral oxygen consumption as morphine does.
C HLORPROMAZINE exerts an inhibitory effect on numerous functions of the central nervous system, particularly on psychomotor and emotional activity. Differing from barbiturates, which have a predominant effect on the cerebrum, chlorpromazine seems to affect primarily the hypothalamic and medullary areas of the brain.' It acts without producing the same degree of somnolence that barbiturates and opiates do. Since opiates and barbiturates depress cerebral oxygen uptake2 without affecting cerebral blood flow, it was decided to do similar studies before and after the administration of chlorpromazine in order to compare the response in normal control subjects.
METHODS AND MATERIALS
Thirteen normotensive control subjects were studied. Nine of these received the chlorpromazine intravenously and 4 received it intramuscularly. The latter 4 subjects were selected because of the rather marked hypotensive responses observed after intravenous administration of the drug which in itself may reduce cerebral blood flow.3 Following intramuscular administration of chlorpromazine, the hypotensive effect was less marked than after intravenous administration. Therefore it was From the Departments of Medicine, Surgery, and Pharmacology, Baylor University College of Medicine, Houston, Tex.
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The subjects were studied in a fasting state in the supine position. Measurements of the pulse rate, respiratory rate, and blood pressure were taken during a control period and repeatedly during the course of each experiment. Arterial blood pressure was recorded by direct intra-arterial manometry. Cerebral blood flow was determined by the nitrous oxide method of Kety and Schmidt.4 Following the control observations, 50 mg. of chlorpromazine were given intravenously (over a 10-minute period of time) to 7 subjects and intramuscularly to 4 subjects. Two additional subjects received 25 mg. and 60 mg., respectively, by the intravenous route. A second cerebral blood flow determination was made 1 hour after the administration of the drug. The blood pH determinations were done on a Beckman pH meter with a water bath maintained at body temperature.
The Van Slyke nomogram was used to estimate CO2 tension (PCO2). Cerebral oxygen consumption (CMRO2) and cerebral vascular resistance (CVR) were calculated as previously described.4'5 The Van Slyke manometric apparatus was used for the gas analysis, and aerosol was used as the hemolytic agent.
RESULTS
The effects of chlorpromazine (Thorazine)* on cerebral blood flow, mean blood pressure, and cerebral oxygen metabolism are recorded in figure 2 is seen the typical hemodynamic response of a normotensive individual given a continuous infusion of hexamethonium.6 As the blood pressure decreases to hypotensive levels, cerebral blood flow is reduced concurrently. This change is associated with an increase in the cerebral arteriovenous oxygen difference and a minimal, or no, alteration in oxygen uptake by the brain.
Further support to the blood pressure effect on cerebral blood flow was furnished when the chlorpromazine was given intramuscularly. Under these circumstances the sharp reduction in mean blood pressure was not observed with the subject in the supine position (as was the case in the current experiment). As a result, cerebral blood flow was not reduced and cerebral arteriovenous oxygen difference was not affected. Furthermore, in those subjects whose reduction in cerebral blood flow was associated with a hypotensive response to intravenously administered chlorpromazine, intravenous infusion of norepinephrine brought about a return toward normal in cerebral blood flow ( figs. 1 and 3) , as the mean blood pressure increased to the control levels. There was no effect on cerebral arteriovenous oxygen difference and no effect on cerebral oxygen uptake ( fig. 1) Response to chlorpromazine given intravenously in a subject who showed a marked reduction in mean blood pressure and cerebral blood flow. The increased extraction of oxygen from the cerebral blood was inadequate to prevent a reduction in cerebral oxygen uptake. When the blood pressure was increased to control levels with norepinephrine both cerebral blood flow and cerebral oxygen uptake increased. blood flow associated with the hypotension due to chlorpromazine administered iuttravenously. This was an erratic response and was apparently due to insufficient oxygen being extracted from the blood flowing through the brain to compensate for the degree of reduction in cerebral blood flow that accompanied the hypotension. When the blood pressure was returned to control levels in these patients by the infusion of norepinephrine, cerebral oxygen consumption, as well as cerebral blood flow, increased toward normal. Such an example is presented in subject 1F.S., in whom the reduction in cerebral 1)1lood flow was associated with a depression in cerebral oxygen consumption ( fig. 3 ). Both alterations were corrected by increasing the blood pressure to control values with the continuous intravenous infusion of norepinephrine. Similar results were achieved by giving norepimephrine to subjects 2 (A.B.), (6 (C.P.) , and 8 (F.S.), who showed a reduction in cerebral blood flow following the administration of chlorpromazine, (figs. 1 and 3). Doses of chlorpromazine up to 300 mg. appear to produce no difference in response from that noted in the current study.7
The metabolic effect of chlorpromazine is quite different from that observed with barbiturates and morphine.' For example, figure 4 presents a typical response to 60 mg. of morphine given intravenously. The morphine did not affect cerebral blood flow, but did cause a marked reduction in cerebral oxygen uptake. 
